Background & Aims
About 528 million people worldwide were living with osteoarthritis (OA)in 2019. With a prevalence of 365 million, the knee is the most frequently affected joint. There are various pharmacological and non-pharmacological treatment modalities available but no consensus guidelines yet formulated. Genicular nerve Radiofrequency ablation(RFA) and dextroprolo-ozone (DPO) therapy are recently emerging techniques for knee osteoarthritis pain management.
AIMS: To compare efficacy between genicular nerve radio frequency ablation and dextroprolo ozone therapy in knee osteoarthritis.
Methods
Patients suffering from chronic knee osteoarthritis of KL (Kellgren and Lawrence system )radiological grade 2 and 3 and received radiofrequency ablation of genicular nerve or dextroprolo ozone therapy between July 2019 and June 2022 in ESI institute of pain management were enrolled. The study was initiated after obtaining approval from institutional ethical committee and informed written consent from the patients. In the present study, data from the patients who were diagnosed with OA grade 2 and grade 3, and underwent RFA and dextro proloozonetherapy between July 2019 and June2022 will be evaluated through the review of patient file records and patient’s interview (telephonic or face-to-face) . The data collected were then analysed.
Results
A total of 115 patients were included in the study ( 50 in RFA group and 65 in dextroproloozone therapy group).
Average duration of significant pain relief following genicular nerve RFA was 7.4 months and following dextroprolo-ozone therapy was 5.7 months.
Conclusions
Although genicular nerve RFA and dextroprolo-ozone therapy offers approximately same duration of significant pain relief but dextroprolo-ozone therapy could be more cost effective alternative than RFA specially in case of low income country .
References
1.FelsonDTEpidemiologyofhipandkneeosteoarthritis.
Epidemiologic Reviews. 1988;10:1.
2.NeogiT.Theepidemiologyandimpactofpainin osteoarthritis.
OsteoarthritisCartilage.2013;21:1145.
3.Michael JW Schlüter-Brust KU Eysel P. Deutsches A The epidemiology,etiology,diagnosis,andtreatmentofosteoarthritisofthe knee. International 2010;107:152.
4.ChoiWJ Hwang SJ Song JG Leem JG Kang YU Radiofrequency treatmentrelieveschronickneeosteoarthritispain:adouble- blind randomized controlled trial. Pain. 2011;152:481.
5.K?rdemir P Çatav S The genicular nerve: radiofrequency lesion applicationforchronickneepain. TurkishJournalofMedicalSciences. 2016;47:268.
6.El-Hakeim EH Elawamy A Kamel EZ Goma SH Gamal RM Fluoroscopic guided radiofrequency of genicular nerves for pain alleviationinchronickneeosteoarthritis:asingle- blindrandomized controlled trial. Pain Physician.
2018;21:169.
7.Jeffries MA, Donica M, Baker LW, Stevenson ME, Annan AC, Humphrey MB. Genome-wide DNA methylation study identifies significantepigenomicchangesinosteoarthriticcartilage.Arthriti s rheumatol. 2014 Oct.66(10):2804-15.
8.Pal CP, Singh P, Chaturvedi S, Pruthi KK, Vij A. Epidemiology of knee osteoarthritis in India and related factors. Indian journal of orthopaedics. 2016 Oct;50(5):518-22.
9.SilmanAJ,HochbergMC.Epidemiologyoftherheumaticdiseases.
Oxford: Oxford university press, 1993.
10.RobertsJ,BurchTA.Osteoarthritisprevalenceinadultsbyage, sex,race and geographic area. Vital Health Stat 11. 1966 Jun. 1-27.
11.Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensusguidelines.OsteoarthritisCartilage.2008 Feb.16(2):137- 62